Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population

NCT00799695 | Completed

• 2 other identifiers: F1003013.13PIRAP
• Study Type: interventional
• Target: 561
• Locations: 1 country
• Sites: 1

Brief Summary

Diabetic retinopathy is the major cause of blindness in working age Americans, and screening for it is cost-effective. There are a quarter of a million people in Southeast Michigan with diabetes and pre-diabetes. Only half of patients with diabetes are screened regularly for diabetic retinopathy, and this proportion has been difficult to increase despite various interventions. Previous research focused on HMO patient groups because preventative care was thought to decrease plan costs. In addition, it was administratively feasible to track patient-doctor interactions. This project builds on published research and institutional experience to determine an effective method for increasing the screening rate, in a mobile, non-HMO population. It uses administrative methods and information technology infrastructures, such as large scale electronic medical records and patient demographic databases, to identify existing patients requiring examinations. Patients were telephoned by a trained service representative who offered and scheduled firm examination appointment times. Hypothesis: Annual screening rates for diabetic retinopathy can be substantially improved in non-HMO patient groups by directly contacting patients and scheduling firm appointment times.

Conditions

Diabetic Retinopathy

Keywords

diabetic retinopathy; screening; annual

Outcome Measures

Primary Outcomes (1)

• a change in the proportion of diabetic patients who acted as a result of the phone contact, and obtained a retina eye exam.

  3 months

Interventions

phone call contact BEHAVIORAL

A sample of subjects who had not completed their annual diabetic screening exams were contacted by phone and offered appointments for eye exams

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• were Henry Ford Health System patients,
• diabetic
• using the BCBSM payer plan

You may not qualify if:

• retina examination in prior year

Sponsors & Collaborators

• Henry Ford Health System: lead
• Blue Cross Blue Shield of Michigan Foundation: collaborator

Study Sites (1)

Henry Ford Health System

Detroit, Michigan, 48202, United States

Location

MeSH Terms

Conditions

Diabetic Retinopathy

Condition Hierarchy (Ancestors)

Retinal Diseases; Eye Diseases; Diabetic Angiopathies; Vascular Diseases; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Endocrine System Diseases

Study Officials

• Robert M Levine,, MD

  Henry Ford Health System

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: November 26, 2008
• First Posted: December 1, 2008
• Study Start: January 1, 2008
• Primary Completion: May 1, 2008
• Study Completion: November 1, 2008
• Last Updated: December 1, 2008

Record last verified: 2008-11

Locations

US (1)